Latest news with #Promega
Business Wire
06-05-2025
- Business
- Business Wire
Promega Madison Achieves ISO 14001 Certification for Environmental Management
MADISON, Wis.--(BUSINESS WIRE)-- Promega Corporation announced today that its headquarters in Madison, Wisconsin has achieved ISO 14001:2015 certification, an internationally recognized standard for environmental management systems. This certification reflects the biotechnology manufacturer's longstanding commitment to environmental stewardship and sustainability. 'This certification embodies the effort we have invested in fostering a culture of environmental responsibility, ensuring environmental compliance and promoting continual improvement across our operations.' Share 'For more than 45 years, Promega has been dedicated to environmental management and sustainable practices within the life sciences industry,' says Jaime Dwight, Director, Environmental Health & Safety and Controlled Substances. 'This certification embodies the effort we have invested in fostering a culture of environmental responsibility, ensuring environmental compliance and promoting continual improvement across our operations.' Promega announced the certification in its 2025 Corporate Responsibility Report, published today on the company's website. In addition to sustainability metrics, the report captures how Promega supports scientists, employees and communities. ISO 14001:2015 Certification ISO 14001:2015 is an internationally recognized standard for environmental management systems. It provides a framework for organizations to identify, manage, monitor and improve their environmental performance. The standard helps businesses reduce waste, comply with regulations and minimize their environmental impact while enhancing sustainability efforts. To achieve this certification, Promega demonstrated a strong environmental management system including adherence to environmental compliance requirements, mitigating environmental impact of our operations, and leadership commitment to sustainable best practices. A thorough review by independent auditors confirmed the company's efforts in these areas. Examples of Promega environmental initiatives include: Innovative product design that incorporates green chemistry and ambient shipping stability A global commitment to sourcing 100% renewable electricity by the end of 2025 Employee-driven programs such as plastic film collection and recycling On-site composting to support the company garden using food and landscaping waste 2025 Corporate Responsibility Report Since 2008, Promega has issued an annual Corporate Responsibility Report detailing its progress in sustainability, product impact, employee well-being and community engagement. Highlights of this year's report include: Supporting Young Scientists: The Promega Rising Researchers Scientific Innovation Awards honor exceptional PhD students around the world with resources, mentorship and a visit to Promega Madison. Giving Back to Communities: The Promega in Action initiative gives Madison-based employees the opportunity to receive up to 40 hours of paid time off to volunteer for a nonprofit organization of their choice. Investing in Research and Innovation: Promega invested 13.8% of its revenue in R&D in 2024, propelling advancements in drug discovery, bioluminescence imaging and cellular metabolism. The 2025 Corporate Responsibility Report contains additional information on how Promega considers the United Nations Sustainable Development Goals (SDGs) in its practices and actions. here. About Promega Corporation Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's portfolio of over 4,000 products supports a range of life science work across areas such as cell biology; DNA, RNA and protein analysis; drug development; human identification and molecular diagnostics. These tools and technologies have grown in their application over the last 45 years and are used today by scientists and technicians in labs for academic and government research, forensics, pharmaceuticals, clinical diagnostics and veterinary, agricultural and environmental testing. Promega is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. Learn more at
Business Wire
22-04-2025
- Business
- Business Wire
EditCo Bio and Promega Partner to Power a New Era of Biologically Relevant Cell-Based Research
REDWOOD CITY, Calif.--(BUSINESS WIRE)--EditCo Bio, Inc. has announced a strategic licensing agreement with Promega Corporation, granting EditCo access to Promega HiBiT, HaloTag®, and NanoLuc® technologies. These advanced protein-tagging and bioluminescent detection systems will be integrated into EditCo's CRISPR knock-in services. This collaboration strengthens EditCo's position as a leader in engineered cell solutions by enabling researchers to generate highly reproducible and reliable gene-edited models for a wide range of applications. Through this agreement, EditCo will not only facilitate precise genomic knock-ins but also offer functional validation services, ensuring that engineered cells maintain proper protein expression, stability, and activity. These capabilities empower researchers with cell models optimized for mechanistic studies, drug screening, and other advanced applications requiring quantitative protein analysis. 'Our collaboration with Promega underscores EditCo's commitment to delivering industry-leading CRISPR-engineered cells that go beyond genetic modification by incorporating functional validation,' said Travis Maures, PhD, Chief Scientific Officer at EditCo Bio. 'By integrating HiBiT, HaloTag, and NanoLuc into our knock-in workflows, we provide researchers with powerful tools to track protein expression, interactions, and activity with high sensitivity and accuracy. This partnership will accelerate discoveries in functional genomics, drug development, and therapeutic research.' 'This agreement accelerates scientific innovation by providing researchers with advanced cellular models engineered for precise functional analysis,' says Tom Livelli, Promega Vice President, Life Sciences. 'Leveraging these technologies enables scientists to probe protein dynamics directly within living cells, empowering deeper insights into complex biological mechanisms.' Expanding Functional Assays with HiBiT, HaloTag, and NanoLuc NanoLuc: A highly sensitive luciferase enzyme that provides an exceptional bioluminescent signal for real-time monitoring of cellular and molecular processes. HiBiT: A small bioluminescent peptide tag that enables sensitive, quantitative analysis of protein expression and interactions in live cells. HaloTag: A versatile protein labeling system that allows covalent attachment of fluorescent and bioluminescent probes for imaging, protein interaction studies, and biochemical assays. EditCo's licensing agreement with Promega enables the development of custom-engineered cell lines incorporating these technologies exclusively for research use. Researchers can leverage these advanced tools to create reliable and reproducible cellular models with functional validation, streamlining experimental workflows and increasing data confidence. For more details on EditCo's CRISPR Knock-in Services featuring HiBiT, HaloTag, and NanoLuc, visit About EditCo Bio, Inc. EditCo Bio is a leader in engineered cell solutions, offering high-quality, functionally validated CRISPR-edited cell lines. With a strong foundation in CRISPR genome engineering, EditCo Bio provides researchers with precise, reproducible, and scalable gene-editing services to advance discoveries in cell and gene therapy, drug development, and basic research. About Promega Corporation Promega Corporation develops innovative technologies for nucleic acid and protein analysis, including proprietary tools like HaloTag®, NanoLuc®, and HiBiT. For over 45 years, its products have advanced research in drug discovery, molecular biology, and diagnostics. Headquartered in Madison, WI, Promega operates in 16 countries with over 50 global distributors. Learn more at
